Cyteir Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Industry
Pharmaceutical Preparations
Location
P.O. Box 80084, Stoneham, MA

Insiders trading volume in the past year

Cyteir Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Braden Michael Leonard 10%+ Owner $11.8M +$846K +7.74% Mar 20, 2024
Droia Invest II SCSp 10%+ Owner $5.98M Jun 22, 2021
Novo Holdings A/S 10%+ Owner $5.95M Jul 19, 2023
Venrock Associates VII, L.P. 10%+ Owner $5.51M Jun 22, 2021
Jean George Director $4.15M Feb 14, 2024
Markus Renschler President and CEO, Director $1.87M Feb 29, 2024
Joseph S. Zakrzewski Director $636K Feb 6, 2024
David Gaiero Chief Financial Officer $173K Feb 29, 2024
John F. Thero Director $38.6K Feb 8, 2024
Stephen H. Sands Director $20.5K Feb 9, 2024
John Paul Secrist Chief Scientific Officer Feb 22, 2022
M. Veness General Counsel Feb 3, 2023
Andrew Gengos Chief Business Officer Feb 22, 2022
Susan Molineaux Director Feb 3, 2023
Karen Hong Director Jun 17, 2021
Janwillem Naesens Director Feb 22, 2022
Jeffrey Humphrey Director Feb 3, 2023
Timothy Romberger Director Feb 3, 2023
Racquel Bracken Director Feb 3, 2023

Recent Insider Transactions by Companies or Individuals for Cyteir Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.